Your session is about to expire
← Back to Search
Sildenafil 25mg Oral Tablet for Prostate Cancer
Phase 3
Waitlist Available
Led By Kuwong B Mwamukonda, MD
Research Sponsored by Brooke Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post surgery
Awards & highlights
Study Summary
This trial will compare the effectiveness of two drugs in helping men regain erectile function after surgery for prostate cancer.
Eligible Conditions
- Prostate Cancer
- Erectile Dysfunction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months post surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Erectile function
Secondary outcome measures
Penile length
Trial Design
3Treatment groups
Active Control
Placebo Group
Group I: Sildenafil 25mg Oral TabletActive Control1 Intervention
25mg sildenafil citrate twice daily
Group II: PentoxifyllineActive Control1 Intervention
400mg pentoxifylline twice daily
Group III: PlaceboPlacebo Group1 Intervention
placebo twice daily
Find a Location
Who is running the clinical trial?
Walter Reed National Military Medical CenterFED
138 Previous Clinical Trials
33,834 Total Patients Enrolled
1 Trials studying Prostate Cancer
8 Patients Enrolled for Prostate Cancer
Brooke Army Medical CenterLead Sponsor
119 Previous Clinical Trials
26,379 Total Patients Enrolled
Kuwong B Mwamukonda, MDPrincipal Investigator - Brooke Army Medical Center
Brooke Army Medical Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger